Serum biomarkers reflecting progression of knee osteoarthritis: a stage-based evaluation of TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13

Knee osteoarthritis (KOA) is a progressive degenerative joint disease characterized by extracellular matrix (ECM) degradation and dysregulated inflammatory signaling. Identifying serum biomarkers associated with radiographic severity may improve early diagnosis, staging, and monitoring of progression. To evaluate stage-dependent and non-linear changes in serum transforming growth factor-β3 (TGF-β3), ADAMTS-4, ADAMTS-5, and matrix metalloproteinase-13 (MMP-13) across Kellgren–Lawrence (KL) grades of KOA. In this cross-sectional study, 200 participants were classified into five groups according to KL grade (KL0–KL4; n = 40 per group). Individuals with systemic inflammatory, metabolic, autoimmune, renal, cardiovascular, or bone metabolism–related disorders, and those using medications affecting cartilage or bone metabolism, were excluded. After overnight fasting, serum TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13 levels were measured by ELISA. Between-group comparisons were performed using one-way ANOVA or Kruskal–Wallis tests with appropriate post-hoc analyses, and data are presented as mean ± standard deviation, unless otherwise stated. ADAMTS-4 differed significantly across KL grades (overall p < 0.00001), showing a non-linear pattern with higher levels in KL1–KL3. ADAMTS-5 demonstrated a pronounced stage-dependent pattern (overall p < 0.00002), peaking in KL1 and declining toward advanced stages. Serum MMP-13 levels did not differ significantly across KL grades (p > 0.05). TGF-β3 levels differed significantly across KL grades (overall p = 0.0015), with lower levels in KL1–KL2 compared with KL0 and intermediate levels in KL3–KL4. ADAMTS-4 and ADAMTS-5 exhibit biphasic, stage-dependent changes during KOA progression, consistent with early enzymatic activation followed by late-stage reduction. Early declines in TGF-β3 may reflect impaired cartilage homeostasis. The observed non-linear, stage-dependent serum patterns—particularly for ADAMTS-4, ADAMTS-5, and TGF-β3—highlight dynamic extracellular matrix remodeling during KOA progression and support the potential value of serum biomarkers as adjuncts to radiographic staging, especially in early disease.

Authors

Institutions

Publication Details

Journal
BMC Musculoskeletal Disorders
Published
2026-02-14
DOI
https://doi.org/10.1186/s12891-026-09613-3
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum biomarkers reflecting progression of knee osteoarthritis: a stage-based evaluation of TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13

Meryem Sedef Dogru, Ömer Esmez, Zubeyde Ercan, Secil Yılmaz
BMC Musculoskeletal Disorders
Osteoarthritis Treatment and Mechanisms
article

Serum biomarkers reflecting progression of knee osteoarthritis: a stage-based evaluation of TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13

Meryem Sedef Dogru, Ömer Esmez, Zubeyde Ercan, Secil Yılmaz
article en

Abstract

Knee osteoarthritis (KOA) is a progressive degenerative joint disease characterized by extracellular matrix (ECM) degradation and dysregulated inflammatory signaling. Identifying serum biomarkers associated with radiographic severity may improve early diagnosis, staging, and monitoring of progression. To evaluate stage-dependent and non-linear changes in serum transforming growth factor-β3 (TGF-β3), ADAMTS-4, ADAMTS-5, and matrix metalloproteinase-13 (MMP-13) across Kellgren–Lawrence (KL) grades of KOA. In this cross-sectional study, 200 participants were classified into five groups according to KL grade (KL0–KL4; n = 40 per group). Individuals with systemic inflammatory, metabolic, autoimmune, renal, cardiovascular, or bone metabolism–related disorders, and those using medications affecting cartilage or bone metabolism, were excluded. After overnight fasting, serum TGF-β3, ADAMTS-4, ADAMTS-5, and MMP-13 levels were measured by ELISA. Between-group comparisons were performed using one-way ANOVA or Kruskal–Wallis tests with appropriate post-hoc analyses, and data are presented as mean ± standard deviation, unless otherwise stated. ADAMTS-4 differed significantly across KL grades (overall p < 0.00001), showing a non-linear pattern with higher levels in KL1–KL3. ADAMTS-5 demonstrated a pronounced stage-dependent pattern (overall p < 0.00002), peaking in KL1 and declining toward advanced stages. Serum MMP-13 levels did not differ significantly across KL grades (p > 0.05). TGF-β3 levels differed significantly across KL grades (overall p = 0.0015), with lower levels in KL1–KL2 compared with KL0 and intermediate levels in KL3–KL4. ADAMTS-4 and ADAMTS-5 exhibit biphasic, stage-dependent changes during KOA progression, consistent with early enzymatic activation followed by late-stage reduction. Early declines in TGF-β3 may reflect impaired cartilage homeostasis. The observed non-linear, stage-dependent serum patterns—particularly for ADAMTS-4, ADAMTS-5, and TGF-β3—highlight dynamic extracellular matrix remodeling during KOA progression and support the potential value of serum biomarkers as adjuncts to radiographic staging, especially in early disease.

BMC Musculoskeletal DisordersVol. 27(1)
University of Turku (FI), Endometriosis UK (GB), University of Health Sciences Antigua (AG)
Good health and well-being
Openalex Percentile: Top 57%
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.